Supportive care

Safety and efficacy of kyphoplasty in the treatment of tumoral disease of the spine. García-Maroto R et al. Rev Esp Cir Ortop Traumatol. 2015 Jun 19. pii: S1888-4415(15)00058-2. doi: 10.1016/j.recot.2015.05.003. [Epub ahead of print]. Risks and Benefits of Bisphosphonate Therapies. Reyes C er al. J Cell Biochem. 2015 Jun 20. doi: 10.1002/jcb.25266. [Epub ahead of print]. Adherence to analgesics for cancer…

General

Differentiated plasma cell myeloma presenting as a solitary spinal amyloidoma: A case report, possible pitfall and review to the literature. Brawanski N et al. Clin Neurol Neurosurg. 2015 Jun 10;137:1-4. doi: 10.1016/j.clineuro.2015.05.027. [Epub ahead of print]. Regulatory Perspective on Minimal Residual Disease Flow Cytometry Testing in Multiple Myeloma. Gormley NJ et al. Cytometry B Clin Cytom. 2015 Jun 23. doi: 10.1002/cyto.b.21268. [Epub ahead of…

Complications of myeloma and its treatments

Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy. Teh BW et al. Br J Haematol. 2015 Jun 24. doi: 10.1111/bjh.13532. [Epub ahead of print]. Induction therapy alters plasma fibrin clot properties in multiple myeloma patients: association with thromboembolic complications. Undas A et al. Blood Coagul Fibrinolysis. 2015 Jun 11. [Epub…

Current treatments

The Feasibility and Efficacy of Dose-Adjusted Bortezomib, Melphalan and Dexamethasone for Transplantation-Ineligible Patients with Newly Diagnosed Multiple Myeloma. Obama K. Acta Haematol. 2015 Jun 11;134(4):229-230. [Epub ahead of print]/ Biosimilar filgrastim (Zarzio®) vs Lenograstim (Myelostim®) for peripheral blood stem cell mobilization in adult patients with myeloma and lymphoma: A single center experience. Marchesi F et al. Leuk Lymphoma. 2015 Jun 23:1-12.…

Supportive care

Comparison of Percutaneous Vertebroplasty and Balloon Kyphoplasty for the Treatment of Single Level Vertebral Compression Fractures: A Meta-analysis of the Literature. Wang H et al. Pain Physician. 2015 May-Jun;18(3):209-22. The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease. Diel IJ et al. Eur J Cancer. 2015 May 11. pii: S0959-8049(15)00373-1. doi: 10.1016/j.ejca.2015.04.017.…

General

Multiple myeloma: new uses for available agents, excitement for the future. Anderson KC. J Natl Compr Canc Netw. 2015 May;13(5 Suppl):694-6. Expanding role of lenalidomide in hematologic malignancies. Ghosh N et al. Cancer Manag Res. 2015 May 2;7:105-19. doi: 10.2147/CMAR.S81310. eCollection 2015. A Rare Variant of Multiple Myeloma; Non-Secretory Myeloma with diffuse osteolytic lesions. Sultan S et al. Gulf J Oncolog. 2015 May;1(18):28-31. Mapping Functions in…

Complications of myeloma and its treatments

Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma. Dogan B et al. Ther Clin Risk Manag. 2015 Apr 30;11:683-9. doi: 10.2147/TCRM.S79232. eCollection 2015. Contribution of Clostridium difficile infection to the development of lower gastrointestinal adverse events during autologous stem cell transplantation. Apewokin S et al, Transpl Infect Dis. 2015 May 19. doi: 10.1111/tid.12403. [Epub ahead of…

Current treatments

Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma. Poenisch W et al. J Cancer Res Clin Oncol. 2015 May 15. [Epub ahead of print]. High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma. Wildes TM et al. Bone Marrow Transplant. 2015 May 11. doi: 10.1038/bmt.2015.106. [Epub…